Biomedical, Clinical & Life Sciences

No applicants // Limit: 1 // Tickets Available: 1 

The ESTEEMED program is intended to expose students to bioengineering research early in their college careers and interest them in potentially pursuing advanced studies in bioengineering or a related field. It will prepare students to join, in their junior and senior years, an honors program, supported by federal or institutional funds, that promotes STEM and entrance into a Ph.D. program. The ultimate goal is for the participants to pursue a Ph.D. or M.D./Ph.D. degree and a subsequent research career integrating engineering and the physical sciences with medicine and biology in academia or industry

No applicants // Limit: 1 // Tickets Available: 1 

This FOA invites applications to participate in the Immune Drivers of Autoimmune Disease (IDAD) cooperative research program, which will focus on defining the immunologic states and dynamics that drive autoimmune disease. The main objective of this program is to enhance our understanding of the immunologic processes, events, and changes that underlie the clinical manifestations of autoimmune diseases, including disease flare, remission, and progression of established disease, as well as the progression from a state of elevated risk to clinical diagnosis of autoimmune disease.

UArizona may submit one application

The program needs to provide research experiences with the intention to extend the skills, experiences, and knowledge of genetic counselors. The program should provide experiences that allow the genetic counselors to enhance skills necessary to formulate and conduct genomic research independently and that is not available through other formal NIH training mechanisms. Research experiences should be in one or more of the areas relevant to NHGRI's research programs - genome sciences, genomic medicine, and ethical, legal, and social implicaions  in genomics research.

No applicants // Limit: 1 // Tickets Available: 1 

This FOA seeks to support programs that include innovative approaches to enhance biomedical engineering (BME) design education to ensure a future workforce that can meet the nation’s needs in biomedical research and healthcare technologies.

Applications are encouraged from institutions that propose to establish new or to enhance existing team-based design courses or programs in undergraduate biomedical engineering departments or other degree-granting programs with biomedical engineering tracks/minors. This FOA targets the education of undergraduate biomedical engineering/bioengineering students in a team-based environment. Health equity and universal design topics must be integrated throughout the educational activities. While current best practices such as multidisciplinary/interdisciplinary education, introduction to the regulatory pathway and other issues related to the commercialization of medical devices, and clinical immersion remain encouraged components of a strong BME program, this FOA also challenges institutions to propose other novel, innovative and/or ground-breaking activities that can form the basis of the next generation of biomedical engineering design education.

B. LaFleur

UArizona may submit one application.

For this FOA, “genomics research” is defined as biological investigation at the scale of the complete genome without having a focus on a single gene, a group of genes, a particular genomic locus, or a specific disease or organ system. “Genomics programs” are defined as research or educational programs that have a complete or substantial focus on genomics research, including both experimental and computational approaches towards genomics. Programs that focus on biological research or education with genetics topics included without a specific focus on genome-scale topics will ordinarily be considered outside the scope of “genomics programs”.

No applicants // Limit: 1 // Tickets Available: 1 

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Catalyst for Infant Health Equity program. The purpose of this new program is to support the implementation of existing action plans that apply data-driven policy and innovative systems strategies to reduce infant mortality (IM) disparities in a specific county/jurisdiction. For the purposes of this NOFO, since “county” is not a term used for all geographic areas, the term “jurisdiction” is also used and refers to tribal areas; the District of Columbia; municipalities within Puerto Rico; and similar geographical areas found within the US-affiliated Pacific Islands and Freely Associated States. The goals of the Catalyst for Infant Health Equity program are twofold: 1) to continue reducing overall IM rates in the United States, and 2) to decrease and ultimately eliminate disparities in IM across racial/ethnic groups by achieving steeper declines for groups with the highest rates. To accelerate disparity reduction, this project seeks to move beyond direct services to implementing targeted policy and systems interventions that will focus on one or more specific social determinants of health (SDOH) domains that contribute to IM disparities in a particular county/jurisdiction.

No applicants // Limit: 1 // Tickets Available: 1 

The purpose of this notice of funding opportunity is to support pre-doctoral fellows’ innovative research to develop and apply computational tools and mathematical methods for modeling the spread of pathogens in healthcare settings (e.g., SARS-CoV-2, healthcare-associated infections [HAIs], antimicrobial resistant organisms [AROs]). This NOFO is intended to increase the number of junior modeling professionals that are trained and experienced in modeling transmission of pathogens in healthcare settings and to contribute to generalizable scientific knowledge through dissemination (e.g., pre-prints, peer-reviewed studies, scientific presentations). The application should be written by the PI/mentor who may or may not name specific pre-doctoral student(s) to conduct the research at the time of application submission.

No applicants // Limit: 1 // Tickets Available: 1 

Only one application per organization will be considered for either Components A and B or Components A, B, and C. Applicants must submit one application, but with separate work plans and budgets for each component.

The Centers for Disease Control and Prevention (CDC), National Center for Environmental Health, Division of Environmental Health Science and Practice announces the availability of fiscal year (FY) 2022 funds for a cooperative agreement to strengthen and modernize environmental health data and surveillance in the United States. The purpose of the funding is to continue building public health capacity and expertise in environmental health surveillance and to modernize data systems to empower public health practitioners, healthcare providers, community members, policy members, and others to make information-driven decisions that affect their health. Since 2002, the Environmental Public Health Tracking Program has provided the United States with accurate and timely standardized information from a nationwide network of environmental health data to help drive actions to improve the health of communities. The information is shared via a network of people and the Environmental Public Health Tracking Network, a web-based system of integrated health and environmental data with components at the national, state, and local levels.

No applicants // Limit: 1 // Tickets Available: 1 

Influenza and other respiratory illnesses, including COVID-19, are important causes of morbidity, mortality, and healthcare burden across all age groups. For influenza and novel vaccines, such as for COVID-19, estimates of vaccine effectiveness in preventing illness and associated complications are needed in order to evaluate the protection provided by nationwide vaccination programs. The goal of this notice of funding opportunity is to support a network of US institutions that can: a) conduct systematic testing for laboratory-confirmed disease due to influenza, SARS-CoV-2 and other respiratory virus infections, b) obtain reliable vaccination information for enrolled patients and c) provide accurate estimates of the effectiveness of vaccines against respiratory viruses, including influenza and SARS-CoV-2 and other respiratory viruses, to prevent medically attended influenza-associated illness in the population for whom vaccination is recommended.

No applicants // Limit: 1 // Tickets Available: 1 

The purpose of this Funding Opportunity Announcement (FOA) is to support pandemic preparedness by providing an opportunity for facility improvements and building systems upgrades at existing BSL3 and BSL4 biocontainment laboratories engaged in research on RNA viruses of pandemic potential to facilitate the conduct of biomedical research on vaccines and therapeutics. NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for the 2019 Novel Coronavirus (COVID-19), and within the provisions described in the "American Rescue Plan Act of 2021

Limited Submission language from the solicitation:

Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility.